Valeant Pharmaceuticals reported $689.94M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US $ 1256M 147M
Ani Pharmaceuticals ANIP:US $ 27.64M 5.58M
Aurora Cannabis Inc ACB:CN C$ 8.57M 5.22M
Biogen BIIB:US $ 434.8M 36.1M
Bristol Myers Squibb BMY:US $ 2882M 62M
Canopy Growth Corp WEED:CN C$ 64.65M 377K
Catalent CTLT:US $ 401M 38M
Corcept Therapeutics CORT:US $ 8.25M 1.02M
Danaher DHR:US $ 2419M 62M
Eli Lilly And LLY:US $ 1659.3M 226M
Endo International Ordinary Shares ENDP:US $ 90.64M 10.36M
Horizon Pharma HZNP:US $ 18.54M 48.48M
JAZZ PHA JAZZ:US $ 74.16M 0.82M
Lannett LCI:US $ 28.57M 2.58M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Pacira Pharmaceuticals PCRX:US $ 13.98M 0.86M
Perrigo Ordinary Shares PRGO:US $ 490.4M 10.8M
Phibro Animal Health PAHC:US $ 89.7M 9.03M
Prestige Brands PBH:US $ 58.11M 2.35M
Revance Therapeutics RVNC:US $ 13.27M 3.25M
Valeant Pharmaceuticals VRX:CN $ 689.94M 218.94M
Vertex Pharmaceuticals VRTX:US $ 198M 24.4M
Zoetis ZTS:US $ 430M 28M